Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A study published in the New England Journal of Medicine found that participants lost an average of 20.9% of their body weight over 72 weeks when taking the highest dose
The drugs are also effective in promoting weight loss if taken according to their treatment plan, which means patients should take the drugs continuously for at least 12 weeks
At the studys conclusion, researchers found that participants who took GLP-1 medications containing semaglutide or tirzepatide had a 41% decrease in their overall risk of developing an obesity-related cancer
We coordinate closely with insurers, exploring all savings avenuessuch as manufacturer discountsto ensure costs dont stand between you and effective treatment
The study found that the people using the GLP-1 receptor medications were less likely to be hospitalized for problems linked to alcohol use disorder, such as intoxication and withdrawal symptoms like delirium than the patients who weren't using the medications
Rybelsus for a more detailed comparison
US$ 28.67
US$ 25.23
US$ 25.78
